MENU
SLS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

SELLAS Life Sciences Group (SLS) Earnings Date & Reports

SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

SLS is expected to report earnings to rise 75.00% to -10 cents per share on May 08

SELLAS Life Sciences Group SLS Stock Earnings Reports
Q1'25
Est.
$-0.10
Q4'24
Beat
by $0.04
Q3'24
Beat
by $0.03
Q2'24
Beat
by $0.04
Q1'24
Beat
by $0.02
The last earnings report on March 20 showed earnings per share of -5 cents, beating the estimate of -10 cents. With 720.75K shares outstanding, the current market capitalization sits at 99.02M.
View a ticker or compare two or three
SLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of biopharmaceuticals

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
7 Times Square
Phone
+1 646 200-5278
Employees
16
Web
https://www.sellaslifesciences.com